Somerset Trust Co trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.6% in the third quarter, according to its ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

During the same period last year, the company earned $5.00 EPS. The firm’s revenue for the quarter was up 20.1% on a ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Amgen (AMGN – Research Report) today and set a price target of $319.00.

Amgen faces a class-action lawsuit over allegations of concealing a $10.7 billion tax dispute with the IRS, with shareholders ...

A federal judge said Amgen must face a proposed class action accusing the drugmaker of waiting too long to tell shareholders ...

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $317.45 which represents a decrease of $-2.21 or -0.69% from the prior close of $319.66. The stock opened at $320.08 and touched a ...

Amgen Inc. closed $29.40 below its 52-week high ($346.85), which the company reached on July 25th.

The fact that multiple Amgen Inc. ( NASDAQ:AMGN ) insiders offloaded a considerable amount of shares over the past ...

Cantor Fitzgerald has recently initiated Amgen Inc (AMGN) stock to Overweight rating, as announced on September 27, 2024, according to Finviz. Earlier, on August 7, 2024, Wells Fargo had reduced the ...

Amgen (AMGN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Yee from ...